Abstract:An increase in the plasma level of Hcy (homocysteine), an intermediate in the catabolism of methionine, has been identified as a risk factor for many diseases including CVD (cardiovascular disease). CVD is the major cause of death in patients with diabetes mellitus. Therefore the study of Hcy metabolism in diabetes mellitus has been a major focus of current research. Studies conducted in our laboratory were able to show that in both Type 1 and Type 2 diabetes with no renal complications, the plasma Hcy levels were lower than in controls. In Type 1 diabetes, increased activities of the trans-sulfuration enzymes were the major cause for the reduction in plasma Hcy. In Type 2 diabetes, BHMT (betaine:homocysteine methyltransferase) was also observed to play a major role in the increased catabolism of Hcy in addition to the trans-sulfuration enzymes. We were also able to demonstrate the direct effect of insulin and the counter-regulatory hormones on the regulation of cystathionine β-synthase and BHMT, which accounts for the changes in the activities of these two enzymes seen in diabetes mellitus. Background Since the observation, by McCully [1], of severe arteriosclerotic lesions in children with HHcy (hyperhomocysteinaemia) and homocysteinuria, a large number of studies have linked moderate HHcy to atherosclerotic disease. Mean plasma tHcy [total Hcy (homocysteine)] was found to be significantly higher both in male and female patients with coronary artery disease compared with controls with angiographically normal coronary arteries [2]. An increase in plasma Hcy of only 12% greater than the upper limit of normal was shown to be associated with an increase by 3.4fold in the risk of myocardial infarction [3]. After adjusting for possible confounders, Arnesen et al. [4] found a relative risk for coronary heart disease of 1.32 for an increase in serum Hcy of 4 μmol/l. A meta-analysis of 27 studies relating Hcy to coronary, cerebrovascular and peripheral arterial vascular diseases showed a very strong relationship between these diseases and tHcy [5]. More recently, a meta-analysis that examined 30 prospective and retrospective studies confirmed that increased plasma Hcy is an independent predictor of ischaemic heart disease although of moderate strength [6]. There are certain situations in which the risk posed by HHcy may be appreciably elevated. One of these is diabetes mellitus. There is evidence that HHcy is a stronger risk factor in patients with Type 2 diabetes [7,8] and in patients with existing coronary disease [9]. It is important, therefore, to understand the origin and metabolism of Hcy as well as the ways in which this is modified in diabetes.

Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation

Hyperhomocysteinemia Promotes Insulin Resistance by Inducing Endoplasmic Reticulum Stress in Adipose Tissue

Homocysteine upregulates resistin production from adipocytes in vivo and in vitro

Excess homocysteine inhibits pancreatic β-cell secretory function by repressing Zbtb20 expression

Irisin Reverses Insulin Resistance in C2C12 Cells Via the P38-Mapk-pgc-1α Pathway.

Homocysteine metabolism in ZDF (type 2) diabetic rats

Nutriproteomics and Nutrigenomics: Exploring the Mechanism Behind Omega-3 Polyunsaturated Fatty Acids, Homocysteine and Glucose Metabolism

Hyperhomocysteinemia Promotes Insulin Resistance and Adipose Tissue Inflammation in PCOS Mice Through Modulating M2 Macrophage Polarization via Estrogen Suppression

Hcy levels in insulin resistance and diabetes

High uric acid directly inhibits insulin signalling and induces insulin resistance

Increase or Decrease Hydrogen Sulfide Exert Opposite Lipolysis, but Reduce Global Insulin Resistance in High Fatty Diet Induced Obese Mice

Homocysteine metabolism in diabetes

Homocysteine Causes Vascular Endothelial Dysfunction by Disrupting Endoplasmic Reticulum Redox Homeostasis.

Novel Clinical Evidence of an Association between Homocysteine and Insulin Resistance in Patients with Hypothyroidism or Subclinical Hypothyroidism

11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes

Impact of hyperhomocysteinemia on insulin resistance in patients with H-type hypertension

Hydrogen Sulphide Reduces Hyperhomocysteinaemia-Induced Endothelial ER Stress by Sulfhydrating Protein Disulphide Isomerase to Attenuate Atherosclerosis.

Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator.

High uric acid promotes dysfunction in pancreatic β cells by blocking IRS2/AKT signalling

Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia

Intermedin Restores Hyperhomocysteinemia-induced Macrophage Polarization and Improves Insulin Resistance in Mice